Jongwon Jeong. (2024). Development of bio-therapeutics for intractable disease: GFRAL antagonist antibody for alleviating chemotherapy-induced cachexia & Primed MSC-sEV for amelioration of COVID-19-induced ARDS. doi: 10.22677/THESIS.200000798073
Inseong Jung. (2024). Development of novel therapeutics and exploration of strategy to enhance their efficacy for advancing cancer immunotherapy. doi: 10.22677/THESIS.200000799931
Eunju Park. (2025). T cell-derived small extracellular vesicles targeting CD24 enhance anti-tumor effect through dual activation of innate and adaptive immunity. doi: 10.22677/THESIS.200000829162